2024
Additive Value of Magnetic Resonance Simulation Before Chemoradiation in Evaluating Treatment Response and Pseudoprogression in High-Grade Gliomas
Yadav D, Upadhyay R, Kumar V, Chen M, Johnson J, Langshaw H, Curl B, Farhat M, Talpur W, Beckham T, Yeboa D, Swanson T, Ghia A, Li J, Chung C. Additive Value of Magnetic Resonance Simulation Before Chemoradiation in Evaluating Treatment Response and Pseudoprogression in High-Grade Gliomas. Practical Radiation Oncology 2024, 14: e449-e457. PMID: 38685448, DOI: 10.1016/j.prro.2024.04.009.Peer-Reviewed Original ResearchPseudo-progressionResponse assessmentInterobserver agreementImprove response assessmentPost-operative MRIFollow-up MRIFollow-up imagingEvaluate treatment responseHigh-grade gliomasIndependent blinded reviewIdentification of patientsClinical trial enrollmentWeeks of RTPartial response(PRStable disease(SDRT planningSalvage treatmentTumor responseEarly time pointsMedian intervalImprove patient outcomesTrue progressionProspective studyTreatment responseTumor progression
2020
Comparison of tumor delineation using dual energy computed tomography versus magnetic resonance imaging in head and neck cancer re-irradiation cases
Ng S, Cardenas C, Elhalawani H, Pollard C, Elgohari B, Fang P, Meheissen M, Guha-Thakurta N, Bahig H, Johnson J, Kamal M, Garden A, Reddy J, Su S, Ferrarotto R, Frank S, Gunn G, Moreno A, Rosenthal D, Fuller C, Phan J. Comparison of tumor delineation using dual energy computed tomography versus magnetic resonance imaging in head and neck cancer re-irradiation cases. Physics And Imaging In Radiation Oncology 2020, 14: 1-5. PMID: 33458306, PMCID: PMC7807720, DOI: 10.1016/j.phro.2020.04.001.Peer-Reviewed Original ResearchMagnetic resonance imagingHigh interobserver agreementInterobserver agreementRe-irradiation casesSkull base sitesTumor delineationRecurrent HNCMultiple imaging modalitiesTumor volumeRadiation oncologistsResonance imagingDual energyInterobserver consistencyImaging modalitiesTreatment planningMedian DSCTomographyMagnetic resonancePatientsOncologistsTumorsDECTHead